Advances in treatments for type 2 diabetes have led to the development of a once-daily injection capable of controlling blood sugar levels that has just been approved by the FDA.

Another Alzheimer’s drug has—mostly—fallen short of researchers’ expectations, drug developer TauRx said in a statement July 27. 

A study published by PLOS ONE discusses how researchers repurposed 3D printers to perform sample preparation and DNA amplification, slashing the cost of these products by thousands of dollars.

Annapolis, MD (PRWEB) July 25, 2016 -- Purview (http://www.purview.net), the patient-driven medical imaging company, announced today the launch of its new medical image CD burning solution, Purview Publisher (http://www.purview.net/purview-publisher). 

Telehealth has been seen as potential path to bringing care to rural communities. Many healthcare providers offer telehealth for primary care, but what about mental care? With iLookin.com, mental healthcare is being brought to everyone both far and wide.

Researchers have developed new software that helps children diagnosed with ADHD minimize symptoms when receiving care at community pediatric practices. Combining medication and care, patients are able to reduce symptoms by 13 points on parent-rated scale of symptoms.

Experts at the Alzheimer’s Association International Conference are pushing for a new pre-dementia type of neurological diagnosis: mild behavioral impairment. 

Researchers have genetically modified the FXa protein, which acts as a kind of bandage on a cellular level, to be even stronger clotting agent.